This event will sweep across six major Swiss cities and feature input from leading neurology experts, such as Dr. Patricia Pozo-Rosich.

This event aims to explore the practical implications of clinical findings from the Atogepant studies. Topics of discussion will not only focus on patient management strategies and goal setting but will delve into the critical question of whether current care standards for patients are sufficient in migraine prophylaxis.

The educational events IOSI Oncobrunch are structured in such a way that the most important advances in all oncology sectors are reviewed over the span of the year. National and international experts are invited for each occasion to focus on the highlights of their discipline. Besides that, Oncobrunches are the starting point to update the internal guidelines for the treatment of various cancers (IOSI Blaubuch).